Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Description complète

Détails bibliographiques

Publié dans:	J Clin Microbiol
Auteurs principaux:	Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2002
Sujets:	Virology
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120267/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11880402/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.3.837-845.2002
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!